University of Minnesota
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).
University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.
University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.
Top-decile sponsor footprint
University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
966 total, page 17 of 20
A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function
NCT01522950
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
NCT01100658
Laser Resurfacing Versus Dermabrasion for Scar Revision
NCT01176448
Quit and Win Contests to Improve Smoking Cessation Among College Students
NCT01096108
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034
Prospective Observation of Exercise Parameters in Advanced Heart Failure
NCT01210573
The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery
NCT01284075
Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
NCT01797367
Simvastatin Therapy for Moderate and Severe COPD
NCT01061671
Sustiva Levels With Use of a Gel Capsule
NCT01087814
Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness
NCT02029989
Movement Velocity Effect on Cortical Reorganization and Finger Function in Stroke
NCT01575366
Journeys to Wellness: A Transplant Candidate Study
NCT01254214
Pediatric Hemiplegia: Synergistic Treatment Using rTMS and CIT
NCT01104064
7T MRS in Parkinson's Disease
NCT01237210
Novel Determinants and Measures of Smokeless Tobacco Use: Study 1
NCT01067586
Vascular Effects of Attention Deficit Hyperactivity Disorder (ADHD) Medications in Youth
NCT01107301
Varenicline and Smoking Cessation in Schizophrenia
NCT01111149
Effects of Genotype on CYP2C9 Drug Interactions
NCT01061112
Food Reward in Native American Women
NCT01623440
Purple Grape Juice in Improving Vascular Health in Childhood Cancer Survivors
NCT01043939
Naltrexone and Hypoglycemia in Type 1 Diabetes
NCT01053078
Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.
NCT02112071
Self-Weighing Instruction Feasibility Study
NCT01966926
Longitudinal Studies of Brain Structure and Function in MPS Disorders
NCT01870375
Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer
NCT01089803
Telehealth Nursing Intervention for Children With Complex Health Care Needs (CCHCN)
NCT01328353
Resistant Starch and Satiety
NCT01187875
The Effect of Exercise on Preventing PostPartum Depression
NCT00961402
Respiratory Virus Hospitalization Study (FLU 003 Plus)
NCT01056185
Improved Breast MRI With SWIFT
NCT01156987
Respiratory Virus Outpatient Study (FLU 002 Plus)
NCT01056354
Pilot Study Using a Wireless Motility Capsule
NCT01102894
Laxation and Satiety Response of Novel Dietary Fibers
NCT01102881
Green Tea and Reduction of Breast Cancer Risk
NCT00917735
Treatment of Cocaine Dependence With Lisdexamfetamine
NCT00958282
Studies of Kidney Transplant Outcome
NCT01277770
GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
NCT00886626
Pharmacogenetics of Warfarin Induction and Inhibition
NCT01447511
Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
NCT01776151
Strategic Timing of Antiretroviral Treatment
NCT00867048
Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care Unit
NCT00872027
Frequency Analysis of Coronary Artery Disease
NCT01043237
Satiety Response of Short Chain Fructooligosaccharide
NCT01100788
Using Alternative Implants for the Surgical Treatment of Hip Fractures (The FAITH Study)
NCT00761813
Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
NCT01797432
Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers
NCT00691132
Use of Botulinum Toxin to Treat Psoriasis
NCT00816517
Training Effects on Skeletal Muscle Fatty Acid Metabolism
NCT00786487
Evaluating Two Exercise Training Programs to Reduce Leg Pain in People With Peripheral Arterial Disease (The EXERT Study)
NCT00895635
What is open in the University of Minnesota pipeline
180 recruiting of 966 indexed (19% open); 671 completed (69%).
Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).
Top condition: Obesity (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Minnesota: open-pipeline peers nationwide
Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 966 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Alabama at Birmingham · 19% recruiting · 1,160 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Minnesota page
966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.
- 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Minnesota pipeline card: 966 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.